Clinical trial NCT00932919: Thought Field Therapy and Cognitive Therapy for Agoraphobia
Official title: Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Agoraphobia
Keywords: Agoraphobia
Cognitive therapy
Thought field therapy
Psychotherapy research
Lead sponsor: Sorlandet Hospital HF
Sponsor class: OTHER_GOV
First posted: 2009-07-07
Enrollment: 72
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Detailed description: Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

Eligibility criteria: Inclusion Criteria:

* Patients ages 18 years or older,
* Patients with agoraphobia,
* Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
* Patients who give a written consent to participate.

Exclusion Criteria:

* Psychosis (past or present),
* Drug abuse or dependency,
* Moderate or high score on suicidal behaviour on the M.I.N.I.,
* Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.

Primary outcomes:
measure: Change in agoraphobic situation scores in ADIS.
timeFrame: Immedeately and 12 months after treatment
Secondary outcomes:
measure: Interference score in ADIS
timeFrame: Immediately and 12 months after treatment
measure: Mobility Inventory
timeFrame: Immediately and 12 months after treatment
measure: Agoraphobic Cognitions Questionnaire
timeFrame: Immediately and 12 months after treatment
measure: Body Sensations Questionnaire
timeFrame: Immediately and 12 months after treatment
measure: BDI
timeFrame: Immediately and 12 months after treatment
measure: BAI
timeFrame: Immediately and 12 months after treatment
measure: WHOQOL-BREF
timeFrame: Immediately and 12 months after treatment
measure: SF-36
timeFrame: Immediately and 12 months after treatment
measure: Safety Seeking Behaviours Questionnaire.
timeFrame: Immediately and 12 months after treatment
measure: Panic scale
timeFrame: Immediately and 12 months after treatment
Other outcomes:
Locations:
city: Arendal
country: Norway
facility: Sorlandet Hospital
Study officials:
affiliation: Sorlandet Hospital HF, Norway
name: Audun C Irgens, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Irgens AC, Hoffart A, Nysaeter TE, Haaland VO, Borge FM, Pripp AH, Martinsen EW, Dammen T. Thought Field Therapy Compared to Cognitive Behavioral Therapy and Wait-List for Agoraphobia: A Randomized, Controlled Study with a 12-Month Follow-up. Front Psychol. 2017 Jun 20;8:1027. doi: 10.3389/fpsyg.2017.01027. eCollection 2017.